Araştırma firması, tividenofusp alfa (DNL310) Biyolojik Lisans Başvurusu’nun (BLA) FDA tarafından kabul edilme potansiyelini, 2024 boyunca daha geniş düzenleyici belirsizlikler arasında baskı gören ...

Baker Brothers’ Q1 2025 portfolio reveals biotech investment trends. See more on their top holdings, stake changes, and ...

Three of VB's underlying holdings with notable upside to their analyst target prices are Denali Therapeutics Inc (Symbol: DNLI), Azenta Inc (Symbol: AZTA), and Vimeo Inc (Symbol: VMEO).

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

A month has gone by since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares have added about 0.7% in that time frame, underperforming the S&P 500.

A month has gone by since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares have added about 0.7% in that time frame, underperforming the S&P 500. Will the recent positive trend ...

Summarize DNLI's latest news. Stifel maintains Buy on Denali Therapeutics stock, $37 target. On Tuesday, Stifel analysts reiterated their Buy rating and $37.00 price target for Denali Therapeutics Inc ...